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ABSTRACT
Several innovations that can improve immunization systems already exist. Some interventions target
service consumers within communities to raise awareness, build trust, improve understanding, remind
caregivers, reward service users, and improve communication. Other interventions target health facilities
to improve access and quality of vaccination services among others. Despite available empirical evidence,
there is a delay in translating innovations into routine practice by immunization programmes.
Drawing on an existing implementation science framework, we propose an interactive, and multi-
perspective model to improve uptake and utilization of available immunization-related innovations in the
African region.
It is important to stress that our framework is by no means prescriptive. The key intention is to advocate
for the entire immunization system to be viewed as an interconnected system of stakeholders, so as to
foster better interaction, and proactive transfer of evidence-based innovation into policy and practice.
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Introduction
Immunization has been lauded as one of the most successful
public health interventions, both in terms of effectiveness and
cost-effectiveness, for ensuring child survival.1 According to
World Health Organization (WHO), about 3 million deaths are
averted yearly because of childhood immunization.2 A recent
study reported that the beneﬁt in treatment cost and loss of pro-
ductivity averted in the lifespan of immunized children is
16 times higher than the initial investment in immunization.3
Further analysis using a full-income approach showed that every
dollar invested in immunization yields an estimated return which
is 44 times higher than the initial cost.3 Thus indicating that
immunizing a child contributes to overall national development.3
To ensure universal access to vaccines for all children, the
WHO, in 1974, launched the Expanded Programme on Immuni-
zation (EPI) as a framework for immunization systems globally.4
To further advance equity in access, the World Health Assembly,
in 2012, endorsed the Global Vaccine Action Plan (GVAP).5 The
GVAP, which is based on six principles, aims to prevent vaccine-
preventable deaths.5
Although top-level policy makers in the African region take
cognizance of the broad social and economic value of immu-
nization, many countries within the region continue to fall
short on key targets in the GVAP.6,7 The 2017 assessment
report of the GVAP revealed that the region achieved only
74% coverage level with third dose of diphtheria-tetanus-per-
tussis containing vaccine (DTP3), which is the lowest com-
pared to other regions of the world.6 According to recent
estimates, 21 out of the 47 countries within the region have
DTP3 coverage below 90%, with Equatorial Guinea, South
Sudan and Nigeria reporting coverage levels as low as 35%,
45%, and 45% respectively.8 In addition, disease eradication
and elimination targets in the region have been set back by
the appearance of new cases of paralytic poliomyelitis due to
wild-type polio virus, and persistence of measles, rubella, and
maternal and neonatal tetanus.6 These setbacks are a result of
the suboptimal performance of the immunization system in
the African region resulting from factors linked to challenges
with regards maintenance of the vaccine cold chain, vaccine
distribution and delivery practices, and vaccine demand and
uptake within countries.9
Evidence based innovations
Several evidence-based innovations that can improve immuniza-
tion systems already exist. In recent years, due to increasing
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mobile phone penetration and expansion of broadband internet
access, the use of mobile health (mHealth) technology has
evolved rapidly even in low- and middle-income countries.10, 11
A mobile based application; the electronic Vaccine Intelligence
Network (eVIN), which enables real-time vaccine stock tracking
and cold chain temperature monitoring is currently in use, with
promising results.12 The success of this mHealth innovation has
attracted the interest of some countries.13
Other interventions to improve delivery of immunization
services that target different levels of the immunization system
have also been tested in some communities. Some interventions
target the immunisation service consumers within communi-
ties to raise awareness, build trust, improve understanding,
remind caregivers, reward service users, and improve commu-
nication. For instance, monetary incentives have been used to
improve immunization coverage.14 Studies have also shown
that home visits and community health education are effective
in improving immunization coverage rates.15, 16 Other inter-
ventions target health systems to improve access and quality of
vaccination services.17
Bridging the know-do gap
Despite available evidence, there is a delay in translating inno-
vations into routine practice by immunization programmes.
Fortunately, a growing body of literature in the nascent ﬁeld of
implementation science on how to bridge this “know-do” gap
now exist and can hasten the transfer of innovations with
proven effectiveness into routine practice.18 In fact, these con-
cepts are already being applied in other health programmes to
optimize service delivery.19
Considering the current performance of immunization sys-
tems in the African region, it is imperative for national pro-
grammes to review current strategies and incorporate new and
existing evidence-based innovations. To sustain uptake of these
evidence-based innovations, country-level immunization sys-
tems would eventually need to be re-organized into knowledge
translation systems that emphasize quick interaction between
all stakeholders (from researchers to healthcare providers).
Such systems would ensure that innovations are quickly trans-
lated into practice for the immunization systems to beneﬁt
individuals and communities in a timely manner.
Moreover, ﬁscal allocation to communicable disease control
(including immunization) are likely to reduce in response to com-
peting demands for funding due to the rising burden of non-com-
municable diseases. Thus, an efﬁcient system is an exigent need.
A proposed model
Drawing on an existing implementation science framework, we
propose an interactive, and multi-perspective model.20 The
proposed model (as shown in Fig. 1 would reduce the time
taken for national immunization systems to become aware of
potentially valuable interventions and strategies, hasten the
incorporation of these strategies into national programs, and
enhance communication between all stakeholders for continu-
ous improvement. This model leverages on already existing
structures within national immunization programmes.
The original framework from which the model is derived
combines aspects of research-to-practice and community-cen-
tered models.20 It was developed by Wandersman and his col-
leagues out of the dire need for new approaches to addressing
know-do gap.20 One of the key feature of the framework is the
bidirectional communication between all stakeholders to ensure
that they understand each other’s needs and perspectives.20 The
United States Center for Disease Control and Prevention (CDC)
uses this framework in violence prevention program to bridge
the gap between development of violence prevention strategies
and application in the ﬁeld.21 In addition to the three categories
of stakeholders (evidence synthesis, program support and ser-
vice delivery) speciﬁed in the original framework, we added a
fourth one; end-users, in our proposed model. This is in recogni-
tion of the value of client outcomes such as satisfaction, and
implementation outcomes such as acceptability and appropri-
ateness in informing how activities can be modiﬁed. We there-
fore grouped immunization stakeholders into four;
a. Immunization evidence synthesis system
b. Immunization program support system
c. Immunization service delivery system
d. Immunization service end-users
Immunization evidence synthesis system
The evidence synthesis system includes National Immunization
Technical Advisory Groups (NITAGs) and other national
entities with research capacity. Since NITAGS already have a
formalized responsibility of providing evidence-based recom-
mendations at national level, they should coordinate this system.
Through a network of research entities, and in close collabora-
tion with other stakeholders within the system, NITAGs should
recommend strategies/innovations or packages of innovations
that EPI leads can implement within their cultural and geo-
graphic context. Using program data including client and imple-
mentation indicators, this system should also recommend
speciﬁc adaptation of innovations to attain best “ﬁt” with cul-
ture, organizational climate and geographic characteristics.
Immunization program support system
The role of the immunization program support system is to
build the general and speciﬁc technical capacity of immuniza-
tion stakeholders in the delivery system. This is to enable
proper implementation of recommended strategies with ﬁdel-
ity. This system can employ various kinds of facilitation strate-
gies to meet its objectives. Stakeholders include national
government agencies primarily responsible for immunization;
nongovernmental, bilateral and multilateral organizations
involved in immunization programming; and the National
Inter-Agency Co-ordinating Committee.
Immunization service delivery system
The service delivery system would comprise the general and
speciﬁc individuals and capacities required by the support sys-
tem to provide quality and safe immunization services to all
children, adolescents and adults that require it in a timely man-
ner. They include health workers in hospitals and clinics, and
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volunteers from community and faith-based organizations
among others. Example of general capacities include manage-
rial and leadership skills, proper use of new and existing routine
immunization recording and reporting tools, vaccine manage-
ment among others.
Immunization service end-users
These stakeholders comprise of individual consumers of vac-
cines which comprise targeted individuals and communities.
Their role is to provide valuable feedback that can be used for
adaptation and improvement of immunization service.
Feedback loop
A key feature of this framework is the bidirectional arrows
between all stakeholders. This indicates the need for infor-
mation sharing and communication between stakeholder.
Such communication would promote better understanding
among stakeholders and encourage them to support each
other’s roles.
Similar to the original framework, budgetary allocation at all
levels of government, external funding, routine immunization
policies at national and state or provincial levels, implementa-
tion climate and availability of existing primary research are
recognized factors that can affect knowledge translation and
should be kept in mind at all time.
Conclusion
Bridging the know-do gap in immunization would take coun-
tries in the African Region closer to achieving immunization
performance targets. It is important to stress that our frame-
work is by no means prescriptive. The key intention is to advo-
cate for the entire immunization system to be viewed as an
interconnected system of stakeholders, so as to foster better
interaction, and proactive transfer of evidence-based innova-
tion into policy and practice in an iterative manner, using data
from these stakeholders to continually adapt strategies to
ensure equitable access to vaccines for all.
Disclosure of potential conﬂicts of interest
No potential conﬂicts of interest were disclosed.
Funding
The work of Abdu A. Adamu and Charles S. Wiysonge is supported by the
South African Medical Research Council and the National Research Foun-
dation of South Africa (Grant Number: 106035).
ORCID
Abdu A. Adamu http://orcid.org/0000-0003-3317-1319
Olalekan A. Uthman http://orcid.org/0000-0002-8567-3081
Charles S. Wiysonge http://orcid.org/0000-0002-1273-4779
Figure 1. Proposed Model for timely transfer of innovation in national immunization systems in the African Region.
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